Global Non-Benzodiazepines Supply, Demand and Key Producers, 2023-2029
The global Non-Benzodiazepines market size is expected to reach $ 1431.5 million by 2029, rising at a market growth of 11.5% CAGR during the forecast period (2023-2029).
Non-benzodiazepines are a relatively new class of hypnotics
This report studies the global Non-Benzodiazepines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-Benzodiazepines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-Benzodiazepines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-Benzodiazepines total production and demand, 2018-2029, (K Units)
Global Non-Benzodiazepines total production value, 2018-2029, (USD Million)
Global Non-Benzodiazepines production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Non-Benzodiazepines consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Non-Benzodiazepines domestic production, consumption, key domestic manufacturers and share
Global Non-Benzodiazepines production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Non-Benzodiazepines production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Non-Benzodiazepines production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Non-Benzodiazepines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Teva Pharmaceuticals, Torrent Pharma, Accord Healthcare, Akorn, Apotex, Fresenius Kabi, Hikma and Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-Benzodiazepines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Non-Benzodiazepines Market, By Region:
1. How big is the global Non-Benzodiazepines market?
2. What is the demand of the global Non-Benzodiazepines market?
3. What is the year over year growth of the global Non-Benzodiazepines market?
4. What is the production and production value of the global Non-Benzodiazepines market?
5. Who are the key producers in the global Non-Benzodiazepines market?
6. What are the growth factors driving the market demand?
Non-benzodiazepines are a relatively new class of hypnotics
This report studies the global Non-Benzodiazepines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Non-Benzodiazepines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-Benzodiazepines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Non-Benzodiazepines total production and demand, 2018-2029, (K Units)
Global Non-Benzodiazepines total production value, 2018-2029, (USD Million)
Global Non-Benzodiazepines production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Non-Benzodiazepines consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Non-Benzodiazepines domestic production, consumption, key domestic manufacturers and share
Global Non-Benzodiazepines production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Non-Benzodiazepines production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Non-Benzodiazepines production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Non-Benzodiazepines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Teva Pharmaceuticals, Torrent Pharma, Accord Healthcare, Akorn, Apotex, Fresenius Kabi, Hikma and Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-Benzodiazepines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Non-Benzodiazepines Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Dexmedetomidine
- Zolpidem
- Eszopiclone
- Zopiclone
- other
- Hospital
- Clinic
- Other
- Pfizer
- Teva Pharmaceuticals
- Torrent Pharma
- Accord Healthcare
- Akorn
- Apotex
- Fresenius Kabi
- Hikma
- Mylan
- Par Pharmaceuticals
- Sandoz
- Sun Pharma
- WG Critical Care
- Athenex
- Chenxin Pharmaceutical
- Huatai Chenguang Pharmaceutical
1. How big is the global Non-Benzodiazepines market?
2. What is the demand of the global Non-Benzodiazepines market?
3. What is the year over year growth of the global Non-Benzodiazepines market?
4. What is the production and production value of the global Non-Benzodiazepines market?
5. Who are the key producers in the global Non-Benzodiazepines market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Non-Benzodiazepines Introduction
1.2 World Non-Benzodiazepines Supply & Forecast
1.2.1 World Non-Benzodiazepines Production Value (2018 & 2022 & 2029)
1.2.2 World Non-Benzodiazepines Production (2018-2029)
1.2.3 World Non-Benzodiazepines Pricing Trends (2018-2029)
1.3 World Non-Benzodiazepines Production by Region (Based on Production Site)
1.3.1 World Non-Benzodiazepines Production Value by Region (2018-2029)
1.3.2 World Non-Benzodiazepines Production by Region (2018-2029)
1.3.3 World Non-Benzodiazepines Average Price by Region (2018-2029)
1.3.4 North America Non-Benzodiazepines Production (2018-2029)
1.3.5 Europe Non-Benzodiazepines Production (2018-2029)
1.3.6 China Non-Benzodiazepines Production (2018-2029)
1.3.7 Japan Non-Benzodiazepines Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-Benzodiazepines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Non-Benzodiazepines Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Non-Benzodiazepines Demand (2018-2029)
2.2 World Non-Benzodiazepines Consumption by Region
2.2.1 World Non-Benzodiazepines Consumption by Region (2018-2023)
2.2.2 World Non-Benzodiazepines Consumption Forecast by Region (2024-2029)
2.3 United States Non-Benzodiazepines Consumption (2018-2029)
2.4 China Non-Benzodiazepines Consumption (2018-2029)
2.5 Europe Non-Benzodiazepines Consumption (2018-2029)
2.6 Japan Non-Benzodiazepines Consumption (2018-2029)
2.7 South Korea Non-Benzodiazepines Consumption (2018-2029)
2.8 ASEAN Non-Benzodiazepines Consumption (2018-2029)
2.9 India Non-Benzodiazepines Consumption (2018-2029)
3 WORLD NON-BENZODIAZEPINES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Non-Benzodiazepines Production Value by Manufacturer (2018-2023)
3.2 World Non-Benzodiazepines Production by Manufacturer (2018-2023)
3.3 World Non-Benzodiazepines Average Price by Manufacturer (2018-2023)
3.4 Non-Benzodiazepines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Non-Benzodiazepines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Non-Benzodiazepines in 2022
3.5.3 Global Concentration Ratios (CR8) for Non-Benzodiazepines in 2022
3.6 Non-Benzodiazepines Market: Overall Company Footprint Analysis
3.6.1 Non-Benzodiazepines Market: Region Footprint
3.6.2 Non-Benzodiazepines Market: Company Product Type Footprint
3.6.3 Non-Benzodiazepines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Non-Benzodiazepines Production Value Comparison
4.1.1 United States VS China: Non-Benzodiazepines Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Non-Benzodiazepines Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Non-Benzodiazepines Production Comparison
4.2.1 United States VS China: Non-Benzodiazepines Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Non-Benzodiazepines Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Non-Benzodiazepines Consumption Comparison
4.3.1 United States VS China: Non-Benzodiazepines Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Non-Benzodiazepines Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Non-Benzodiazepines Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Non-Benzodiazepines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Non-Benzodiazepines Production Value (2018-2023)
4.4.3 United States Based Manufacturers Non-Benzodiazepines Production (2018-2023)
4.5 China Based Non-Benzodiazepines Manufacturers and Market Share
4.5.1 China Based Non-Benzodiazepines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Non-Benzodiazepines Production Value (2018-2023)
4.5.3 China Based Manufacturers Non-Benzodiazepines Production (2018-2023)
4.6 Rest of World Based Non-Benzodiazepines Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Non-Benzodiazepines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Non-Benzodiazepines Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Non-Benzodiazepines Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-Benzodiazepines Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Dexmedetomidine
5.2.2 Zolpidem
5.2.3 Eszopiclone
5.2.4 Zopiclone
5.2.5 other
5.3 Market Segment by Type
5.3.1 World Non-Benzodiazepines Production by Type (2018-2029)
5.3.2 World Non-Benzodiazepines Production Value by Type (2018-2029)
5.3.3 World Non-Benzodiazepines Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Non-Benzodiazepines Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Non-Benzodiazepines Production by Application (2018-2029)
6.3.2 World Non-Benzodiazepines Production Value by Application (2018-2029)
6.3.3 World Non-Benzodiazepines Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Non-Benzodiazepines Product and Services
7.1.4 Pfizer Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Details
7.2.2 Teva Pharmaceuticals Major Business
7.2.3 Teva Pharmaceuticals Non-Benzodiazepines Product and Services
7.2.4 Teva Pharmaceuticals Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Teva Pharmaceuticals Recent Developments/Updates
7.2.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Torrent Pharma
7.3.1 Torrent Pharma Details
7.3.2 Torrent Pharma Major Business
7.3.3 Torrent Pharma Non-Benzodiazepines Product and Services
7.3.4 Torrent Pharma Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Torrent Pharma Recent Developments/Updates
7.3.6 Torrent Pharma Competitive Strengths & Weaknesses
7.4 Accord Healthcare
7.4.1 Accord Healthcare Details
7.4.2 Accord Healthcare Major Business
7.4.3 Accord Healthcare Non-Benzodiazepines Product and Services
7.4.4 Accord Healthcare Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Accord Healthcare Recent Developments/Updates
7.4.6 Accord Healthcare Competitive Strengths & Weaknesses
7.5 Akorn
7.5.1 Akorn Details
7.5.2 Akorn Major Business
7.5.3 Akorn Non-Benzodiazepines Product and Services
7.5.4 Akorn Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Akorn Recent Developments/Updates
7.5.6 Akorn Competitive Strengths & Weaknesses
7.6 Apotex
7.6.1 Apotex Details
7.6.2 Apotex Major Business
7.6.3 Apotex Non-Benzodiazepines Product and Services
7.6.4 Apotex Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Apotex Recent Developments/Updates
7.6.6 Apotex Competitive Strengths & Weaknesses
7.7 Fresenius Kabi
7.7.1 Fresenius Kabi Details
7.7.2 Fresenius Kabi Major Business
7.7.3 Fresenius Kabi Non-Benzodiazepines Product and Services
7.7.4 Fresenius Kabi Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Fresenius Kabi Recent Developments/Updates
7.7.6 Fresenius Kabi Competitive Strengths & Weaknesses
7.8 Hikma
7.8.1 Hikma Details
7.8.2 Hikma Major Business
7.8.3 Hikma Non-Benzodiazepines Product and Services
7.8.4 Hikma Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Hikma Recent Developments/Updates
7.8.6 Hikma Competitive Strengths & Weaknesses
7.9 Mylan
7.9.1 Mylan Details
7.9.2 Mylan Major Business
7.9.3 Mylan Non-Benzodiazepines Product and Services
7.9.4 Mylan Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Mylan Recent Developments/Updates
7.9.6 Mylan Competitive Strengths & Weaknesses
7.10 Par Pharmaceuticals
7.10.1 Par Pharmaceuticals Details
7.10.2 Par Pharmaceuticals Major Business
7.10.3 Par Pharmaceuticals Non-Benzodiazepines Product and Services
7.10.4 Par Pharmaceuticals Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Par Pharmaceuticals Recent Developments/Updates
7.10.6 Par Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Sandoz
7.11.1 Sandoz Details
7.11.2 Sandoz Major Business
7.11.3 Sandoz Non-Benzodiazepines Product and Services
7.11.4 Sandoz Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Sandoz Recent Developments/Updates
7.11.6 Sandoz Competitive Strengths & Weaknesses
7.12 Sun Pharma
7.12.1 Sun Pharma Details
7.12.2 Sun Pharma Major Business
7.12.3 Sun Pharma Non-Benzodiazepines Product and Services
7.12.4 Sun Pharma Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Sun Pharma Recent Developments/Updates
7.12.6 Sun Pharma Competitive Strengths & Weaknesses
7.13 WG Critical Care
7.13.1 WG Critical Care Details
7.13.2 WG Critical Care Major Business
7.13.3 WG Critical Care Non-Benzodiazepines Product and Services
7.13.4 WG Critical Care Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 WG Critical Care Recent Developments/Updates
7.13.6 WG Critical Care Competitive Strengths & Weaknesses
7.14 Athenex
7.14.1 Athenex Details
7.14.2 Athenex Major Business
7.14.3 Athenex Non-Benzodiazepines Product and Services
7.14.4 Athenex Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Athenex Recent Developments/Updates
7.14.6 Athenex Competitive Strengths & Weaknesses
7.15 Chenxin Pharmaceutical
7.15.1 Chenxin Pharmaceutical Details
7.15.2 Chenxin Pharmaceutical Major Business
7.15.3 Chenxin Pharmaceutical Non-Benzodiazepines Product and Services
7.15.4 Chenxin Pharmaceutical Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Chenxin Pharmaceutical Recent Developments/Updates
7.15.6 Chenxin Pharmaceutical Competitive Strengths & Weaknesses
7.16 Huatai Chenguang Pharmaceutical
7.16.1 Huatai Chenguang Pharmaceutical Details
7.16.2 Huatai Chenguang Pharmaceutical Major Business
7.16.3 Huatai Chenguang Pharmaceutical Non-Benzodiazepines Product and Services
7.16.4 Huatai Chenguang Pharmaceutical Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Huatai Chenguang Pharmaceutical Recent Developments/Updates
7.16.6 Huatai Chenguang Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Non-Benzodiazepines Industry Chain
8.2 Non-Benzodiazepines Upstream Analysis
8.2.1 Non-Benzodiazepines Core Raw Materials
8.2.2 Main Manufacturers of Non-Benzodiazepines Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Non-Benzodiazepines Production Mode
8.6 Non-Benzodiazepines Procurement Model
8.7 Non-Benzodiazepines Industry Sales Model and Sales Channels
8.7.1 Non-Benzodiazepines Sales Model
8.7.2 Non-Benzodiazepines Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Non-Benzodiazepines Introduction
1.2 World Non-Benzodiazepines Supply & Forecast
1.2.1 World Non-Benzodiazepines Production Value (2018 & 2022 & 2029)
1.2.2 World Non-Benzodiazepines Production (2018-2029)
1.2.3 World Non-Benzodiazepines Pricing Trends (2018-2029)
1.3 World Non-Benzodiazepines Production by Region (Based on Production Site)
1.3.1 World Non-Benzodiazepines Production Value by Region (2018-2029)
1.3.2 World Non-Benzodiazepines Production by Region (2018-2029)
1.3.3 World Non-Benzodiazepines Average Price by Region (2018-2029)
1.3.4 North America Non-Benzodiazepines Production (2018-2029)
1.3.5 Europe Non-Benzodiazepines Production (2018-2029)
1.3.6 China Non-Benzodiazepines Production (2018-2029)
1.3.7 Japan Non-Benzodiazepines Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Non-Benzodiazepines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Non-Benzodiazepines Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Non-Benzodiazepines Demand (2018-2029)
2.2 World Non-Benzodiazepines Consumption by Region
2.2.1 World Non-Benzodiazepines Consumption by Region (2018-2023)
2.2.2 World Non-Benzodiazepines Consumption Forecast by Region (2024-2029)
2.3 United States Non-Benzodiazepines Consumption (2018-2029)
2.4 China Non-Benzodiazepines Consumption (2018-2029)
2.5 Europe Non-Benzodiazepines Consumption (2018-2029)
2.6 Japan Non-Benzodiazepines Consumption (2018-2029)
2.7 South Korea Non-Benzodiazepines Consumption (2018-2029)
2.8 ASEAN Non-Benzodiazepines Consumption (2018-2029)
2.9 India Non-Benzodiazepines Consumption (2018-2029)
3 WORLD NON-BENZODIAZEPINES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Non-Benzodiazepines Production Value by Manufacturer (2018-2023)
3.2 World Non-Benzodiazepines Production by Manufacturer (2018-2023)
3.3 World Non-Benzodiazepines Average Price by Manufacturer (2018-2023)
3.4 Non-Benzodiazepines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Non-Benzodiazepines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Non-Benzodiazepines in 2022
3.5.3 Global Concentration Ratios (CR8) for Non-Benzodiazepines in 2022
3.6 Non-Benzodiazepines Market: Overall Company Footprint Analysis
3.6.1 Non-Benzodiazepines Market: Region Footprint
3.6.2 Non-Benzodiazepines Market: Company Product Type Footprint
3.6.3 Non-Benzodiazepines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Non-Benzodiazepines Production Value Comparison
4.1.1 United States VS China: Non-Benzodiazepines Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Non-Benzodiazepines Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Non-Benzodiazepines Production Comparison
4.2.1 United States VS China: Non-Benzodiazepines Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Non-Benzodiazepines Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Non-Benzodiazepines Consumption Comparison
4.3.1 United States VS China: Non-Benzodiazepines Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Non-Benzodiazepines Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Non-Benzodiazepines Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Non-Benzodiazepines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Non-Benzodiazepines Production Value (2018-2023)
4.4.3 United States Based Manufacturers Non-Benzodiazepines Production (2018-2023)
4.5 China Based Non-Benzodiazepines Manufacturers and Market Share
4.5.1 China Based Non-Benzodiazepines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Non-Benzodiazepines Production Value (2018-2023)
4.5.3 China Based Manufacturers Non-Benzodiazepines Production (2018-2023)
4.6 Rest of World Based Non-Benzodiazepines Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Non-Benzodiazepines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Non-Benzodiazepines Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Non-Benzodiazepines Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Non-Benzodiazepines Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Dexmedetomidine
5.2.2 Zolpidem
5.2.3 Eszopiclone
5.2.4 Zopiclone
5.2.5 other
5.3 Market Segment by Type
5.3.1 World Non-Benzodiazepines Production by Type (2018-2029)
5.3.2 World Non-Benzodiazepines Production Value by Type (2018-2029)
5.3.3 World Non-Benzodiazepines Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Non-Benzodiazepines Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Non-Benzodiazepines Production by Application (2018-2029)
6.3.2 World Non-Benzodiazepines Production Value by Application (2018-2029)
6.3.3 World Non-Benzodiazepines Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Non-Benzodiazepines Product and Services
7.1.4 Pfizer Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Details
7.2.2 Teva Pharmaceuticals Major Business
7.2.3 Teva Pharmaceuticals Non-Benzodiazepines Product and Services
7.2.4 Teva Pharmaceuticals Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Teva Pharmaceuticals Recent Developments/Updates
7.2.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Torrent Pharma
7.3.1 Torrent Pharma Details
7.3.2 Torrent Pharma Major Business
7.3.3 Torrent Pharma Non-Benzodiazepines Product and Services
7.3.4 Torrent Pharma Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Torrent Pharma Recent Developments/Updates
7.3.6 Torrent Pharma Competitive Strengths & Weaknesses
7.4 Accord Healthcare
7.4.1 Accord Healthcare Details
7.4.2 Accord Healthcare Major Business
7.4.3 Accord Healthcare Non-Benzodiazepines Product and Services
7.4.4 Accord Healthcare Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Accord Healthcare Recent Developments/Updates
7.4.6 Accord Healthcare Competitive Strengths & Weaknesses
7.5 Akorn
7.5.1 Akorn Details
7.5.2 Akorn Major Business
7.5.3 Akorn Non-Benzodiazepines Product and Services
7.5.4 Akorn Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Akorn Recent Developments/Updates
7.5.6 Akorn Competitive Strengths & Weaknesses
7.6 Apotex
7.6.1 Apotex Details
7.6.2 Apotex Major Business
7.6.3 Apotex Non-Benzodiazepines Product and Services
7.6.4 Apotex Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Apotex Recent Developments/Updates
7.6.6 Apotex Competitive Strengths & Weaknesses
7.7 Fresenius Kabi
7.7.1 Fresenius Kabi Details
7.7.2 Fresenius Kabi Major Business
7.7.3 Fresenius Kabi Non-Benzodiazepines Product and Services
7.7.4 Fresenius Kabi Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Fresenius Kabi Recent Developments/Updates
7.7.6 Fresenius Kabi Competitive Strengths & Weaknesses
7.8 Hikma
7.8.1 Hikma Details
7.8.2 Hikma Major Business
7.8.3 Hikma Non-Benzodiazepines Product and Services
7.8.4 Hikma Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Hikma Recent Developments/Updates
7.8.6 Hikma Competitive Strengths & Weaknesses
7.9 Mylan
7.9.1 Mylan Details
7.9.2 Mylan Major Business
7.9.3 Mylan Non-Benzodiazepines Product and Services
7.9.4 Mylan Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Mylan Recent Developments/Updates
7.9.6 Mylan Competitive Strengths & Weaknesses
7.10 Par Pharmaceuticals
7.10.1 Par Pharmaceuticals Details
7.10.2 Par Pharmaceuticals Major Business
7.10.3 Par Pharmaceuticals Non-Benzodiazepines Product and Services
7.10.4 Par Pharmaceuticals Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Par Pharmaceuticals Recent Developments/Updates
7.10.6 Par Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Sandoz
7.11.1 Sandoz Details
7.11.2 Sandoz Major Business
7.11.3 Sandoz Non-Benzodiazepines Product and Services
7.11.4 Sandoz Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Sandoz Recent Developments/Updates
7.11.6 Sandoz Competitive Strengths & Weaknesses
7.12 Sun Pharma
7.12.1 Sun Pharma Details
7.12.2 Sun Pharma Major Business
7.12.3 Sun Pharma Non-Benzodiazepines Product and Services
7.12.4 Sun Pharma Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Sun Pharma Recent Developments/Updates
7.12.6 Sun Pharma Competitive Strengths & Weaknesses
7.13 WG Critical Care
7.13.1 WG Critical Care Details
7.13.2 WG Critical Care Major Business
7.13.3 WG Critical Care Non-Benzodiazepines Product and Services
7.13.4 WG Critical Care Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 WG Critical Care Recent Developments/Updates
7.13.6 WG Critical Care Competitive Strengths & Weaknesses
7.14 Athenex
7.14.1 Athenex Details
7.14.2 Athenex Major Business
7.14.3 Athenex Non-Benzodiazepines Product and Services
7.14.4 Athenex Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Athenex Recent Developments/Updates
7.14.6 Athenex Competitive Strengths & Weaknesses
7.15 Chenxin Pharmaceutical
7.15.1 Chenxin Pharmaceutical Details
7.15.2 Chenxin Pharmaceutical Major Business
7.15.3 Chenxin Pharmaceutical Non-Benzodiazepines Product and Services
7.15.4 Chenxin Pharmaceutical Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Chenxin Pharmaceutical Recent Developments/Updates
7.15.6 Chenxin Pharmaceutical Competitive Strengths & Weaknesses
7.16 Huatai Chenguang Pharmaceutical
7.16.1 Huatai Chenguang Pharmaceutical Details
7.16.2 Huatai Chenguang Pharmaceutical Major Business
7.16.3 Huatai Chenguang Pharmaceutical Non-Benzodiazepines Product and Services
7.16.4 Huatai Chenguang Pharmaceutical Non-Benzodiazepines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Huatai Chenguang Pharmaceutical Recent Developments/Updates
7.16.6 Huatai Chenguang Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Non-Benzodiazepines Industry Chain
8.2 Non-Benzodiazepines Upstream Analysis
8.2.1 Non-Benzodiazepines Core Raw Materials
8.2.2 Main Manufacturers of Non-Benzodiazepines Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Non-Benzodiazepines Production Mode
8.6 Non-Benzodiazepines Procurement Model
8.7 Non-Benzodiazepines Industry Sales Model and Sales Channels
8.7.1 Non-Benzodiazepines Sales Model
8.7.2 Non-Benzodiazepines Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Non-Benzodiazepines Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Non-Benzodiazepines Production Value by Region (2018-2023) & (USD Million)
Table 3. World Non-Benzodiazepines Production Value by Region (2024-2029) & (USD Million)
Table 4. World Non-Benzodiazepines Production Value Market Share by Region (2018-2023)
Table 5. World Non-Benzodiazepines Production Value Market Share by Region (2024-2029)
Table 6. World Non-Benzodiazepines Production by Region (2018-2023) & (K Units)
Table 7. World Non-Benzodiazepines Production by Region (2024-2029) & (K Units)
Table 8. World Non-Benzodiazepines Production Market Share by Region (2018-2023)
Table 9. World Non-Benzodiazepines Production Market Share by Region (2024-2029)
Table 10. World Non-Benzodiazepines Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Non-Benzodiazepines Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Non-Benzodiazepines Major Market Trends
Table 13. World Non-Benzodiazepines Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Non-Benzodiazepines Consumption by Region (2018-2023) & (K Units)
Table 15. World Non-Benzodiazepines Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Non-Benzodiazepines Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Non-Benzodiazepines Producers in 2022
Table 18. World Non-Benzodiazepines Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Non-Benzodiazepines Producers in 2022
Table 20. World Non-Benzodiazepines Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Non-Benzodiazepines Company Evaluation Quadrant
Table 22. World Non-Benzodiazepines Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Non-Benzodiazepines Production Site of Key Manufacturer
Table 24. Non-Benzodiazepines Market: Company Product Type Footprint
Table 25. Non-Benzodiazepines Market: Company Product Application Footprint
Table 26. Non-Benzodiazepines Competitive Factors
Table 27. Non-Benzodiazepines New Entrant and Capacity Expansion Plans
Table 28. Non-Benzodiazepines Mergers & Acquisitions Activity
Table 29. United States VS China Non-Benzodiazepines Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Non-Benzodiazepines Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Non-Benzodiazepines Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Non-Benzodiazepines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Non-Benzodiazepines Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Non-Benzodiazepines Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Non-Benzodiazepines Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Non-Benzodiazepines Production Market Share (2018-2023)
Table 37. China Based Non-Benzodiazepines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Non-Benzodiazepines Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Non-Benzodiazepines Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Non-Benzodiazepines Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Non-Benzodiazepines Production Market Share (2018-2023)
Table 42. Rest of World Based Non-Benzodiazepines Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Non-Benzodiazepines Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Non-Benzodiazepines Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Non-Benzodiazepines Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Non-Benzodiazepines Production Market Share (2018-2023)
Table 47. World Non-Benzodiazepines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Non-Benzodiazepines Production by Type (2018-2023) & (K Units)
Table 49. World Non-Benzodiazepines Production by Type (2024-2029) & (K Units)
Table 50. World Non-Benzodiazepines Production Value by Type (2018-2023) & (USD Million)
Table 51. World Non-Benzodiazepines Production Value by Type (2024-2029) & (USD Million)
Table 52. World Non-Benzodiazepines Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Non-Benzodiazepines Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Non-Benzodiazepines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Non-Benzodiazepines Production by Application (2018-2023) & (K Units)
Table 56. World Non-Benzodiazepines Production by Application (2024-2029) & (K Units)
Table 57. World Non-Benzodiazepines Production Value by Application (2018-2023) & (USD Million)
Table 58. World Non-Benzodiazepines Production Value by Application (2024-2029) & (USD Million)
Table 59. World Non-Benzodiazepines Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Non-Benzodiazepines Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Non-Benzodiazepines Product and Services
Table 64. Pfizer Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceuticals Major Business
Table 69. Teva Pharmaceuticals Non-Benzodiazepines Product and Services
Table 70. Teva Pharmaceuticals Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Teva Pharmaceuticals Recent Developments/Updates
Table 72. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Torrent Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Torrent Pharma Major Business
Table 75. Torrent Pharma Non-Benzodiazepines Product and Services
Table 76. Torrent Pharma Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Torrent Pharma Recent Developments/Updates
Table 78. Torrent Pharma Competitive Strengths & Weaknesses
Table 79. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 80. Accord Healthcare Major Business
Table 81. Accord Healthcare Non-Benzodiazepines Product and Services
Table 82. Accord Healthcare Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Accord Healthcare Recent Developments/Updates
Table 84. Accord Healthcare Competitive Strengths & Weaknesses
Table 85. Akorn Basic Information, Manufacturing Base and Competitors
Table 86. Akorn Major Business
Table 87. Akorn Non-Benzodiazepines Product and Services
Table 88. Akorn Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Akorn Recent Developments/Updates
Table 90. Akorn Competitive Strengths & Weaknesses
Table 91. Apotex Basic Information, Manufacturing Base and Competitors
Table 92. Apotex Major Business
Table 93. Apotex Non-Benzodiazepines Product and Services
Table 94. Apotex Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Apotex Recent Developments/Updates
Table 96. Apotex Competitive Strengths & Weaknesses
Table 97. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 98. Fresenius Kabi Major Business
Table 99. Fresenius Kabi Non-Benzodiazepines Product and Services
Table 100. Fresenius Kabi Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Fresenius Kabi Recent Developments/Updates
Table 102. Fresenius Kabi Competitive Strengths & Weaknesses
Table 103. Hikma Basic Information, Manufacturing Base and Competitors
Table 104. Hikma Major Business
Table 105. Hikma Non-Benzodiazepines Product and Services
Table 106. Hikma Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Hikma Recent Developments/Updates
Table 108. Hikma Competitive Strengths & Weaknesses
Table 109. Mylan Basic Information, Manufacturing Base and Competitors
Table 110. Mylan Major Business
Table 111. Mylan Non-Benzodiazepines Product and Services
Table 112. Mylan Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Mylan Recent Developments/Updates
Table 114. Mylan Competitive Strengths & Weaknesses
Table 115. Par Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Par Pharmaceuticals Major Business
Table 117. Par Pharmaceuticals Non-Benzodiazepines Product and Services
Table 118. Par Pharmaceuticals Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Par Pharmaceuticals Recent Developments/Updates
Table 120. Par Pharmaceuticals Competitive Strengths & Weaknesses
Table 121. Sandoz Basic Information, Manufacturing Base and Competitors
Table 122. Sandoz Major Business
Table 123. Sandoz Non-Benzodiazepines Product and Services
Table 124. Sandoz Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Sandoz Recent Developments/Updates
Table 126. Sandoz Competitive Strengths & Weaknesses
Table 127. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 128. Sun Pharma Major Business
Table 129. Sun Pharma Non-Benzodiazepines Product and Services
Table 130. Sun Pharma Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Sun Pharma Recent Developments/Updates
Table 132. Sun Pharma Competitive Strengths & Weaknesses
Table 133. WG Critical Care Basic Information, Manufacturing Base and Competitors
Table 134. WG Critical Care Major Business
Table 135. WG Critical Care Non-Benzodiazepines Product and Services
Table 136. WG Critical Care Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. WG Critical Care Recent Developments/Updates
Table 138. WG Critical Care Competitive Strengths & Weaknesses
Table 139. Athenex Basic Information, Manufacturing Base and Competitors
Table 140. Athenex Major Business
Table 141. Athenex Non-Benzodiazepines Product and Services
Table 142. Athenex Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Athenex Recent Developments/Updates
Table 144. Athenex Competitive Strengths & Weaknesses
Table 145. Chenxin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 146. Chenxin Pharmaceutical Major Business
Table 147. Chenxin Pharmaceutical Non-Benzodiazepines Product and Services
Table 148. Chenxin Pharmaceutical Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Chenxin Pharmaceutical Recent Developments/Updates
Table 150. Huatai Chenguang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 151. Huatai Chenguang Pharmaceutical Major Business
Table 152. Huatai Chenguang Pharmaceutical Non-Benzodiazepines Product and Services
Table 153. Huatai Chenguang Pharmaceutical Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Non-Benzodiazepines Upstream (Raw Materials)
Table 155. Non-Benzodiazepines Typical Customers
Table 156. Non-Benzodiazepines Typical Distributors
List of Figure
Figure 1. Non-Benzodiazepines Picture
Figure 2. World Non-Benzodiazepines Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Non-Benzodiazepines Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Non-Benzodiazepines Production (2018-2029) & (K Units)
Figure 5. World Non-Benzodiazepines Average Price (2018-2029) & (US$/Unit)
Figure 6. World Non-Benzodiazepines Production Value Market Share by Region (2018-2029)
Figure 7. World Non-Benzodiazepines Production Market Share by Region (2018-2029)
Figure 8. North America Non-Benzodiazepines Production (2018-2029) & (K Units)
Figure 9. Europe Non-Benzodiazepines Production (2018-2029) & (K Units)
Figure 10. China Non-Benzodiazepines Production (2018-2029) & (K Units)
Figure 11. Japan Non-Benzodiazepines Production (2018-2029) & (K Units)
Figure 12. Non-Benzodiazepines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 15. World Non-Benzodiazepines Consumption Market Share by Region (2018-2029)
Figure 16. United States Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 17. China Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 18. Europe Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 19. Japan Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 20. South Korea Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 22. India Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Non-Benzodiazepines by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Non-Benzodiazepines Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Non-Benzodiazepines Markets in 2022
Figure 26. United States VS China: Non-Benzodiazepines Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Non-Benzodiazepines Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Non-Benzodiazepines Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Non-Benzodiazepines Production Market Share 2022
Figure 30. China Based Manufacturers Non-Benzodiazepines Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Non-Benzodiazepines Production Market Share 2022
Figure 32. World Non-Benzodiazepines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Non-Benzodiazepines Production Value Market Share by Type in 2022
Figure 34. Dexmedetomidine
Figure 35. Zolpidem
Figure 36. Eszopiclone
Figure 37. Zopiclone
Figure 38. other
Figure 39. World Non-Benzodiazepines Production Market Share by Type (2018-2029)
Figure 40. World Non-Benzodiazepines Production Value Market Share by Type (2018-2029)
Figure 41. World Non-Benzodiazepines Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World Non-Benzodiazepines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World Non-Benzodiazepines Production Value Market Share by Application in 2022
Figure 44. Hospital
Figure 45. Clinic
Figure 46. Other
Figure 47. World Non-Benzodiazepines Production Market Share by Application (2018-2029)
Figure 48. World Non-Benzodiazepines Production Value Market Share by Application (2018-2029)
Figure 49. World Non-Benzodiazepines Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Non-Benzodiazepines Industry Chain
Figure 51. Non-Benzodiazepines Procurement Model
Figure 52. Non-Benzodiazepines Sales Model
Figure 53. Non-Benzodiazepines Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Table 1. World Non-Benzodiazepines Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Non-Benzodiazepines Production Value by Region (2018-2023) & (USD Million)
Table 3. World Non-Benzodiazepines Production Value by Region (2024-2029) & (USD Million)
Table 4. World Non-Benzodiazepines Production Value Market Share by Region (2018-2023)
Table 5. World Non-Benzodiazepines Production Value Market Share by Region (2024-2029)
Table 6. World Non-Benzodiazepines Production by Region (2018-2023) & (K Units)
Table 7. World Non-Benzodiazepines Production by Region (2024-2029) & (K Units)
Table 8. World Non-Benzodiazepines Production Market Share by Region (2018-2023)
Table 9. World Non-Benzodiazepines Production Market Share by Region (2024-2029)
Table 10. World Non-Benzodiazepines Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Non-Benzodiazepines Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Non-Benzodiazepines Major Market Trends
Table 13. World Non-Benzodiazepines Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Non-Benzodiazepines Consumption by Region (2018-2023) & (K Units)
Table 15. World Non-Benzodiazepines Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Non-Benzodiazepines Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Non-Benzodiazepines Producers in 2022
Table 18. World Non-Benzodiazepines Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Non-Benzodiazepines Producers in 2022
Table 20. World Non-Benzodiazepines Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Non-Benzodiazepines Company Evaluation Quadrant
Table 22. World Non-Benzodiazepines Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Non-Benzodiazepines Production Site of Key Manufacturer
Table 24. Non-Benzodiazepines Market: Company Product Type Footprint
Table 25. Non-Benzodiazepines Market: Company Product Application Footprint
Table 26. Non-Benzodiazepines Competitive Factors
Table 27. Non-Benzodiazepines New Entrant and Capacity Expansion Plans
Table 28. Non-Benzodiazepines Mergers & Acquisitions Activity
Table 29. United States VS China Non-Benzodiazepines Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Non-Benzodiazepines Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Non-Benzodiazepines Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Non-Benzodiazepines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Non-Benzodiazepines Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Non-Benzodiazepines Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Non-Benzodiazepines Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Non-Benzodiazepines Production Market Share (2018-2023)
Table 37. China Based Non-Benzodiazepines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Non-Benzodiazepines Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Non-Benzodiazepines Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Non-Benzodiazepines Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Non-Benzodiazepines Production Market Share (2018-2023)
Table 42. Rest of World Based Non-Benzodiazepines Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Non-Benzodiazepines Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Non-Benzodiazepines Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Non-Benzodiazepines Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Non-Benzodiazepines Production Market Share (2018-2023)
Table 47. World Non-Benzodiazepines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Non-Benzodiazepines Production by Type (2018-2023) & (K Units)
Table 49. World Non-Benzodiazepines Production by Type (2024-2029) & (K Units)
Table 50. World Non-Benzodiazepines Production Value by Type (2018-2023) & (USD Million)
Table 51. World Non-Benzodiazepines Production Value by Type (2024-2029) & (USD Million)
Table 52. World Non-Benzodiazepines Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Non-Benzodiazepines Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Non-Benzodiazepines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Non-Benzodiazepines Production by Application (2018-2023) & (K Units)
Table 56. World Non-Benzodiazepines Production by Application (2024-2029) & (K Units)
Table 57. World Non-Benzodiazepines Production Value by Application (2018-2023) & (USD Million)
Table 58. World Non-Benzodiazepines Production Value by Application (2024-2029) & (USD Million)
Table 59. World Non-Benzodiazepines Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Non-Benzodiazepines Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Non-Benzodiazepines Product and Services
Table 64. Pfizer Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceuticals Major Business
Table 69. Teva Pharmaceuticals Non-Benzodiazepines Product and Services
Table 70. Teva Pharmaceuticals Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Teva Pharmaceuticals Recent Developments/Updates
Table 72. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Torrent Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Torrent Pharma Major Business
Table 75. Torrent Pharma Non-Benzodiazepines Product and Services
Table 76. Torrent Pharma Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Torrent Pharma Recent Developments/Updates
Table 78. Torrent Pharma Competitive Strengths & Weaknesses
Table 79. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 80. Accord Healthcare Major Business
Table 81. Accord Healthcare Non-Benzodiazepines Product and Services
Table 82. Accord Healthcare Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Accord Healthcare Recent Developments/Updates
Table 84. Accord Healthcare Competitive Strengths & Weaknesses
Table 85. Akorn Basic Information, Manufacturing Base and Competitors
Table 86. Akorn Major Business
Table 87. Akorn Non-Benzodiazepines Product and Services
Table 88. Akorn Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Akorn Recent Developments/Updates
Table 90. Akorn Competitive Strengths & Weaknesses
Table 91. Apotex Basic Information, Manufacturing Base and Competitors
Table 92. Apotex Major Business
Table 93. Apotex Non-Benzodiazepines Product and Services
Table 94. Apotex Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Apotex Recent Developments/Updates
Table 96. Apotex Competitive Strengths & Weaknesses
Table 97. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 98. Fresenius Kabi Major Business
Table 99. Fresenius Kabi Non-Benzodiazepines Product and Services
Table 100. Fresenius Kabi Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Fresenius Kabi Recent Developments/Updates
Table 102. Fresenius Kabi Competitive Strengths & Weaknesses
Table 103. Hikma Basic Information, Manufacturing Base and Competitors
Table 104. Hikma Major Business
Table 105. Hikma Non-Benzodiazepines Product and Services
Table 106. Hikma Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Hikma Recent Developments/Updates
Table 108. Hikma Competitive Strengths & Weaknesses
Table 109. Mylan Basic Information, Manufacturing Base and Competitors
Table 110. Mylan Major Business
Table 111. Mylan Non-Benzodiazepines Product and Services
Table 112. Mylan Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Mylan Recent Developments/Updates
Table 114. Mylan Competitive Strengths & Weaknesses
Table 115. Par Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Par Pharmaceuticals Major Business
Table 117. Par Pharmaceuticals Non-Benzodiazepines Product and Services
Table 118. Par Pharmaceuticals Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Par Pharmaceuticals Recent Developments/Updates
Table 120. Par Pharmaceuticals Competitive Strengths & Weaknesses
Table 121. Sandoz Basic Information, Manufacturing Base and Competitors
Table 122. Sandoz Major Business
Table 123. Sandoz Non-Benzodiazepines Product and Services
Table 124. Sandoz Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Sandoz Recent Developments/Updates
Table 126. Sandoz Competitive Strengths & Weaknesses
Table 127. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 128. Sun Pharma Major Business
Table 129. Sun Pharma Non-Benzodiazepines Product and Services
Table 130. Sun Pharma Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Sun Pharma Recent Developments/Updates
Table 132. Sun Pharma Competitive Strengths & Weaknesses
Table 133. WG Critical Care Basic Information, Manufacturing Base and Competitors
Table 134. WG Critical Care Major Business
Table 135. WG Critical Care Non-Benzodiazepines Product and Services
Table 136. WG Critical Care Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. WG Critical Care Recent Developments/Updates
Table 138. WG Critical Care Competitive Strengths & Weaknesses
Table 139. Athenex Basic Information, Manufacturing Base and Competitors
Table 140. Athenex Major Business
Table 141. Athenex Non-Benzodiazepines Product and Services
Table 142. Athenex Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Athenex Recent Developments/Updates
Table 144. Athenex Competitive Strengths & Weaknesses
Table 145. Chenxin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 146. Chenxin Pharmaceutical Major Business
Table 147. Chenxin Pharmaceutical Non-Benzodiazepines Product and Services
Table 148. Chenxin Pharmaceutical Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Chenxin Pharmaceutical Recent Developments/Updates
Table 150. Huatai Chenguang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 151. Huatai Chenguang Pharmaceutical Major Business
Table 152. Huatai Chenguang Pharmaceutical Non-Benzodiazepines Product and Services
Table 153. Huatai Chenguang Pharmaceutical Non-Benzodiazepines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Non-Benzodiazepines Upstream (Raw Materials)
Table 155. Non-Benzodiazepines Typical Customers
Table 156. Non-Benzodiazepines Typical Distributors
List of Figure
Figure 1. Non-Benzodiazepines Picture
Figure 2. World Non-Benzodiazepines Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Non-Benzodiazepines Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Non-Benzodiazepines Production (2018-2029) & (K Units)
Figure 5. World Non-Benzodiazepines Average Price (2018-2029) & (US$/Unit)
Figure 6. World Non-Benzodiazepines Production Value Market Share by Region (2018-2029)
Figure 7. World Non-Benzodiazepines Production Market Share by Region (2018-2029)
Figure 8. North America Non-Benzodiazepines Production (2018-2029) & (K Units)
Figure 9. Europe Non-Benzodiazepines Production (2018-2029) & (K Units)
Figure 10. China Non-Benzodiazepines Production (2018-2029) & (K Units)
Figure 11. Japan Non-Benzodiazepines Production (2018-2029) & (K Units)
Figure 12. Non-Benzodiazepines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 15. World Non-Benzodiazepines Consumption Market Share by Region (2018-2029)
Figure 16. United States Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 17. China Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 18. Europe Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 19. Japan Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 20. South Korea Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 22. India Non-Benzodiazepines Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Non-Benzodiazepines by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Non-Benzodiazepines Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Non-Benzodiazepines Markets in 2022
Figure 26. United States VS China: Non-Benzodiazepines Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Non-Benzodiazepines Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Non-Benzodiazepines Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Non-Benzodiazepines Production Market Share 2022
Figure 30. China Based Manufacturers Non-Benzodiazepines Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Non-Benzodiazepines Production Market Share 2022
Figure 32. World Non-Benzodiazepines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Non-Benzodiazepines Production Value Market Share by Type in 2022
Figure 34. Dexmedetomidine
Figure 35. Zolpidem
Figure 36. Eszopiclone
Figure 37. Zopiclone
Figure 38. other
Figure 39. World Non-Benzodiazepines Production Market Share by Type (2018-2029)
Figure 40. World Non-Benzodiazepines Production Value Market Share by Type (2018-2029)
Figure 41. World Non-Benzodiazepines Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World Non-Benzodiazepines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World Non-Benzodiazepines Production Value Market Share by Application in 2022
Figure 44. Hospital
Figure 45. Clinic
Figure 46. Other
Figure 47. World Non-Benzodiazepines Production Market Share by Application (2018-2029)
Figure 48. World Non-Benzodiazepines Production Value Market Share by Application (2018-2029)
Figure 49. World Non-Benzodiazepines Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Non-Benzodiazepines Industry Chain
Figure 51. Non-Benzodiazepines Procurement Model
Figure 52. Non-Benzodiazepines Sales Model
Figure 53. Non-Benzodiazepines Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
